-
Mashup Score: 0Senaparib Receives NMPA Approval As First-Line Maintenance in Ovarian Cancer - 49 minute(s) ago
Senaparib has received marketing authorization in China as a first-line maintenance therapy for advanced ovarian cancer.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 4Study Identifies How Ovarian Cancer Protects Itself, Paves Way for Improved Immunotherapy Approach - 3 day(s) ago
Eczema-linked protein helps cancer survive, suggesting potential for skin drug-based treatment.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Eczema-linked protein helps cancer survive, suggesting potential for skin drug-based treatment. @IcahnInstitute @MountSinaiNYC #gyncsm #Oncology #MedTwitter https://t.co/azxFwqNKGA
-
-
Mashup Score: 8Pembrolizumab/Chemo, Followed by Olaparib Maintenance, Boosts PFS in Advanced Ovarian Cancer - 1 month(s) ago
Pembrolizumab plus chemotherapy, followed by olaparib with or without bevacizumab, improved PFS in advanced ovarian cancer.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Pembrolizumab/Chemo, Followed by Olaparib Maintenance, Boosts PFS in Advanced Ovarian Cancer #gyncsm #oncology #medtwitter https://t.co/JAzcORWoFo
-
-
Mashup Score: 8Pembrolizumab/Chemo, Followed by Olaparib Maintenance, Boosts PFS in Advanced Ovarian Cancer - 2 month(s) ago
Pembrolizumab plus chemotherapy, followed by olaparib with or without bevacizumab, improved PFS in advanced ovarian cancer.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Pembrolizumab/Chemo, Followed by Olaparib Maintenance, Boosts PFS in Advanced Ovarian Cancer #gyncsm #oncology #medtwitter https://t.co/JAzcORWoFo
-
-
Mashup Score: 8Pembrolizumab/Chemo, Followed by Olaparib Maintenance, Boosts PFS in Advanced Ovarian Cancer - 2 month(s) ago
Pembrolizumab plus chemotherapy, followed by olaparib with or without bevacizumab, improved PFS in advanced ovarian cancer.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Pembrolizumab/Chemo, Followed by Olaparib Maintenance, Boosts PFS in Advanced Ovarian Cancer #gyncsm #oncology #medtwitter https://t.co/JAzcORWoFo
-
-
Mashup Score: 6
Experts in gynecologic oncology highlight multiple practice-altering clinical trial updates presented at ESMO and beyond in ovarian, cervical, and endometrial cancers.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens @myESMO @AngelesSecord #gyncsm #oncology #MedTwitter https://t.co/ZFMNJOD32D
-
-
Mashup Score: 6
Experts in gynecologic oncology highlight multiple practice-altering clinical trial updates presented at ESMO and beyond in ovarian, cervical, and endometrial cancers.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens @myESMO @AngelesSecord #gyncsm #oncology #MedTwitter https://t.co/ZFMNJOD32D
-
-
Mashup Score: 6
Experts in gynecologic oncology highlight multiple practice-altering clinical trial updates presented at ESMO and beyond in ovarian, cervical, and endometrial cancers.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Gynecologic Cancer Paradigm Sees Huge Gains With FDA-Approved Regimens @myESMO @AngelesSecord #gyncsm #oncology #MedTwitter https://t.co/ZFMNJOD32D
-
-
Mashup Score: 2
Bintrafusp alfa elicited responses in patients with recurrent/metastatic cervical cancer, warranting further exploration of TGF-β-targeted therapies.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Bintrafusp Alfa Induces Responses in Post-Platinum Metastatic Cervical Cancer @uamshealth @uamscancer @JAMAOnc #gyncsm #oncology #medtwitter https://t.co/YDg10jrfQ6
-
-
Mashup Score: 2
Bintrafusp alfa elicited responses in patients with recurrent/metastatic cervical cancer, warranting further exploration of TGF-β-targeted therapies.
Source: www.onclive.comCategories: General Medicine News, Oncologists1Tweet-
Bintrafusp Alfa Induces Responses in Post-Platinum Metastatic Cervical Cancer @uamshealth @uamscancer @JAMAOnc #gyncsm #oncology #medtwitter https://t.co/YDg10jrfQ6
-
Senaparib has received marketing authorization in China as a first-line maintenance therapy for advanced ovarian cancer. #gyncsm #oncology #MedTwitter https://t.co/uS7d8tEjYr